EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Compounds as Modulators of Ferroptosis: Mechanistic Insights and Therapeutic Prospects in Breast Cancer

Haotong He, Haoyang Yu, Hefeng Zhou, Guozhen Cui iD, Min Shao

Biomolecules · 2025

DOI: 10.3390/biom15091308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Haotong He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Basic Teaching Department, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China. Hauptthemen laut MEDLINE: Ferroptosis, Breast Neoplasms, Biological Products, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Basic Research Program (Natural Science).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most prevalent malignant tumor in women. However, its clinical management is severely hindered by three interconnected challenges that limit long-term survival: treatment resistance, metastatic dissemination, and immunological evasion. Ferroptosis, an iron-dependent form of regulated cell death, is emerging as a novel strategy to overcome these obstacles. Furthermore, it demonstrates significant potential in inhibiting tumor metastasis and modifying the anti-tumor immune microenvironment, which provides a novel approach to address the core dilemma of breast cancer. Natural products have emerged as significant sources of ferroptosis inducers owing to their distinctive chemical variety, multi-target regulatory capabilities, and acceptable safety profile. Data increasingly indicates that several natural compounds can function as effective inducers or sensitizers of ferroptosis cell death. This review provides a thorough evaluation of current progress in harnessing natural ingredients to trigger ferroptosis for breast cancer treatment. It also elucidates the fundamental molecular mechanisms. Furthermore, it encapsulates therapeutic efficacy in preclinical models. Ultimately, it rigorously evaluates existing constraints and delineates potential and barriers for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBreast NeoplasmsBiological ProductsAntineoplastic AgentsHumansFemaleAnimalsTumor Microenvironment

Stichwörter der Autor:innen

breast cancerdrug resistanceferroptosisferroptosis inducerslead compoundsnatural compoundsphytochemicals

Substanzen

Biological ProductsAntineoplastic Agents

Autor:innen und Institutionen

  • Basic Teaching Department, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China.
  • Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China.

ORCID-Profile: Guozhen Cui

Förderung

  • Guizhou Provincial Basic Research Program (Natural Science)

Zitieren

APA

He, H., Yu, H., Zhou, H., Cui, G., & Shao, M. (2025). Natural Compounds as Modulators of Ferroptosis: Mechanistic Insights and Therapeutic Prospects in Breast Cancer. Biomolecules. https://doi.org/10.3390/biom15091308

Vancouver

He H, Yu H, Zhou H, Cui G, Shao M. Natural Compounds as Modulators of Ferroptosis: Mechanistic Insights and Therapeutic Prospects in Breast Cancer. Biomolecules. 2025. doi:10.3390/biom15091308

BibTeX
@article{He2025,
  author = {He, Haotong and Yu, Haoyang and Zhou, Hefeng and Cui, Guozhen and Shao, Min},
  title = {Natural Compounds as Modulators of Ferroptosis: Mechanistic Insights and Therapeutic Prospects in Breast Cancer},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091308}
}
Kostenlos starten →